Skip to main content

Publisher: Elsevier

Volume 129, Supplement, May 1995

The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: a clinicopathological study
pp. 11-12(2)
Authors: Chaudhuri, K.R.; Crump, S.; Al-Sarraj, S.; Anderson, V.; Cavanagh, J.; Leigh, P.N.

Favourites:
ADD

Pharmacokinetics and tolerability of ventricularly administered superoxide dismutase in monkeys and preliminary clinical observations in familial ALS
pp. 13-18(6)
Authors: Smith, R.A.; Balis, F.M.; Ott, K.H.; Elsberry, D.D.; Sherman, M.R.; Saifer, M.G.P.

Favourites:
ADD

Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial
pp. 19-26(8)
Authors: Pinto, A.C.; Evangelista, T.; Carvalho, M.; Alves, M.A.; Luis, M.L.S.

Favourites:
ADD

Mortality risk stratification in amyotrophic lateral sclerosis
pp. 27-27(1)
Authors: Louwerse, E.S.; Bossuyt, P.M.M.; Weverling, G.J.; de Jong, J.M.B.V.

Favourites:
ADD

Baseline assessments in amyotrophic lateral sclerosis trials
pp. 28-28(1)
Authors: Bossuyt, P.M.M.; Louwerse, E.S.; Weverling, G.J.; de Jong, J.M.B.V.

Favourites:
ADD

Prognostic values of electroneurographic and electromyographic features in amyotrophic lateral sclerosis
pp. 29-29(1)
Authors: Louwerse, E.S.; Meyjes, F.E.P.; Sillevis Smitt, J.H.; Redekop, W.K.; Bossuyt, P.M.M.; de Jong, J.M.B.V.; de Visser, B.W.O.

Favourites:
ADD

Transcranial magnetic stimulation as a diagnostic and prognostic test in amyotrophic lateral sclerosis
pp. 30-34(5)
Authors: Claus, D.; Brunholzl, C.; Kerling, F.P.; Henschel, S.

Favourites:
ADD

Phrenic nerve conduction in amyotrophic lateral sclerosis
pp. 35-37(3)
Authors: Evangelista, T.; Carvalho, M.; Pinto, A.; Luis, M.d.L.S.

Favourites:
ADD

Thoracic radicular symptoms in amyotrophic lateral sclerosis
pp. 38-41(4)
Authors: Newman, D.S.; Aggarwal, S.K.; Silbergleit, R.

Favourites:
ADD

Amyotrophic lateral sclerosis and pregnancy
pp. 42-43(2)
Authors: Vincent, O.; Rodriguez-Ithurralde, D.

Favourites:
ADD

A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis
pp. 44-46(3)
Authors: Abrahams, S.; Leigh, P.N.; Kew, J.J.M.; Goldstein, L.H.; Lloyd, C.M.L.; Brooks, D.J.

Favourites:
ADD

Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass
pp. 47-49(3)
Authors: Nau, K.L.; Bromberg, M.B.; Forshew, D.A.; Katch, V.L.

Favourites:
ADD

Disease progression and perceptions of health in patients with motor neurone disease
pp. 50-53(4)
Authors: Young, C.A.; Tedman, B.M.; Williams, I.R.

Favourites:
ADD

Cognitive deficits in non-demented amyotrophic lateral sclerosis patients: a neuropsychological investigation
pp. 54-55(2)
Authors: Abrahams, S.; Goldstein, L.H.; Lloyd, C.M.; Brooks, D.J.; Leigh, P.N.

Favourites:
ADD

Differential diagnosis in spinal and bulbar muscular atrophy clinical and molecular aspects
pp. 56-57(2)
Authors: Jobsis, G.J.; Louwerse, E.S.; de Visser, M.; Wolterman, R.A.; Bolhuis, P.A.; Busch, H.F.M.; Bruggenwirth, H.T.; Baas, F.; Wiersinga, W.M.; Koelman, J.H.T.M.; de Jong, J.M.B.V.

Favourites:
ADD

MND risk factors: an epidemiological study in the North West of England
pp. 61-64(4)
Authors: Mitchell, J.D.; Davies, R.B.; Al-Hamad, A.; Gatrell, A.C.; Batterby, G.

Favourites:
ADD

Solutions to old problems in the quantitation of the central nervous system
pp. 65-67(3)
Authors: Pakkenberg, B.; Gundersen, H.J.G.

Favourites:
ADD

Synaptic vesicle proteins, synaptophysin and chromogranin A in amyotrophic lateral sclerosis
pp. 68-74(7)
Authors: Schiffer, D.; Cordera, S.; Giordana, M.T.; Attanasio, A.; Pezzulo, T.

Favourites:
ADD

Involvement of the amygdala, dentate and hippocampus in motor neuron disease
pp. 75-78(4)
Authors: Anderson, V.E.R.; Cairns, N.J.; Leigh, P.N.

Favourites:
ADD

Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis)
pp. 85-89(5)
Authors: Jones, A.P.; Gunawardena, W.J.; Coutinho, C.M.A.; Gatt, J.A.; Shaw, I.C.; Mitchell, J.D.

Favourites:
ADD

Superoxide dismutase activity in lymphoblastoid cells from motor neurone disease/amyotrophic lateral sclerosis (MND/ALS) patients
pp. 90-92(3)
Authors: Garofalo, O.; Figlewicz, D.A.; Thomas, S.M.; Butler, R.; Lebuis, L.; Rouleau, G.; Meininger, V.; Leigh, P.N.

Favourites:
ADD

Cu,Zn SOD in German families with ALS
pp. 93-95(3)
Authors: Bachus, R.; Claus, A.; Megow, D.; Brockmoller, J.; Porstmann, T.; Gericke, C.A.; Riepe, M.; Kuther, G.; Zierz, S.; Ludolph, A.C.

Favourites:
ADD

Alteration of superoxide dismutase activity in the anterior horn in motoneuron disease patients
pp. 96-98(3)
Authors: Fitzmaurice, P.S.; Shaw, I.C.; Mitchell, J.D.

Favourites:
ADD

Glutamate-receptor elicited acetylcholinesterase release in mouse spinal cord slice: a model of early excitotoxic injury
pp. 104-106(3)
Authors: Rodriguez-Ithurralde, D.; Olivera, S.; Migues, V.; Vincent, O.; Salazar, R.

Favourites:
ADD

Toxicity of sulphur-containing compounds to neuronal cell lines
pp. 107-108(2)
Authors: Pean, A.R.; Parsons, R.B.; Waring, R.H.; Williams, A.C.; Ramsden, D.B.

Favourites:
ADD

Ciliary neurotrophic factor receptor expression in spinal cord and motor cortex in amyotrophic lateral sclerosis
pp. 109-113(5)
Authors: Duberley, R.M.; Johnson, I.P.; Anand, P.; Swash, M.; Martin, J.; Leigh, P.N.; Zeman, S.

Favourites:
ADD

The insulin-like growth factor signaling system and ALS neurotrophic factor treatment strategies
pp. 114-121(8)
Authors: Festoff, B.W.; Yang, S.X.; Vaught, J.; Bryan, C.; Ma, J.Y.

Favourites:
ADD

Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease
pp. 122-126(5)
Authors: Hantai, D.; Akaaboune, M.; Lagord, C.; Murawsky, M.; Houenou, L.J.; Festoff, B.W.; Vaught, J.L.; Rieger, F.; Blondet, B.

Favourites:
ADD

Effect of -endorphin and α-melanotropin on muscle wasting in mice
pp. 127-130(4)
Authors: Smith, M.E.; Hughes, S.

Favourites:
ADD

Androgen-controlled specific gene expression in neuroblastoma cells
pp. 131-135(5)
Authors: Yerramilli-Rao, P.; Garofalo, O.; Whatley, S.; Leigh, P.N.; Gallo J.-M.

Favourites:
ADD

Cytotoxic changes in A172 glioblastoma cells exposed to serum Ig from patients with motor neurone disease
pp. 136-137(2)
Authors: Parkes, A.B.; Rickards, C.R.; Rees, P.; Scanlon, M.F.

Favourites:
ADD

Cytotoxic effects of ALS serum on human cell lines
pp. 138-139(2)
Authors: Jansson, I.; Ekblom, J.; Karimi, R.; Walum, E.; Aquilonius, S.

Favourites:
ADD

HTLV tax-rex DNA and antibodies in idiopathic amyotrophic lateral sclerosis
pp. 140-144(5)
Authors: Ferrante, P.; Westarp, M.E.; Mancuso, R.; Puricelli, S.; Westarp, M.P.; Mini, M.; Caputo, D.; Zuffolato, M.R.

Favourites:
ADD

Sporadic ALS/MND: a global neurodegeneration with retroviral involvement?
pp. 145-147(3)
Authors: Westarp, M.E.; Ferrante, P.; Perron, H.; Bartmann, P.; Kornhuber, H.H.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more